Liraglutide for patients with non-alcoholic steatohepatitis.
The Article by Matthew Armstrong and colleagues (Feb 13, p 679) reports different outcomes to those initially registered in the trial protocol.
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Jezik: | English |
| Izdano: |
Elsevier
2016
|